All In Biotech

Drug Trial Radar · NCT04811092

Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients

Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 321 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

321

Actual

Start

Mar 18, 2022

Primary completion

Apr 3, 2025

Study completion Apr 3, 2025

Sponsor

Sponsor type
Industry
First posted
Mar 23, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the effects of sotatercept (MK-7962, formerly called ACE-011) treatment (plus background pulmonary arterial hypertension \[PAH\] therapy) versus placebo (plus background PAH therapy) on time to clinical worsening (TTCW) in participants who are newly diagnosed with PAH and are at intermediate or high-risk of disease progression.

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • SotaterceptDrug

    SC injection

  • PlaceboOther

    Placebo-matched SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Median Time to Clinical WorseningTime frame: Up to ~35 months

Locations

152 sites in 27 countries. Site status is shown where the registry gives one.

  • Arizona Pulmonary Specialists ( Site 1010)

    Scottsdale, Arizona

  • University of Arizona ( Site 1006)

    Tucson, Arizona

  • University of California San Diego ( Site 1002)

    La Jolla, California

  • UCLA Medical Center ( Site 1068)

    Los Angeles, California

  • University of California Irvine ( Site 1086)

    Orange, California

  • Santa Barbara Pulmonary Associates ( Site 1060)

    Santa Barbara, California

  • University of California Davis Medical Center ( Site 1064)

    Sherman Oaks, California

  • University of Colorado Hospital ( Site 1013)

    Aurora, Colorado

  • AdventHealth Medical Group Advanced Lung Disease ( Site 1058)

    Orlando, Florida

  • University of Iowa Hospital and Clinics ( Site 1050)

    Iowa City, Iowa

  • Johns Hopkins Hospital ( Site 1036)

    Baltimore, Maryland

  • Tufts Medical Center - PPDS ( Site 1014)

    Boston, Massachusetts

  • Boston Medical Center ( Site 1012)

    Boston, Massachusetts

  • University of Michigan ( Site 1011)

    Ann Arbor, Michigan

  • University of Kansas Medical Center ( Site 1020)

    Kansas City, Missouri

  • Washington University School of Medicine ( Site 1022)

    St Louis, Missouri

  • University of New Mexico, Health Sciences Center ( Site 1048)

    Albuquerque, New Mexico

  • NYU Langone Health ( Site 1052)

    New York, New York

  • University of North Carolina at Chapel Hill ( Site 1042)

    Chapel Hill, North Carolina

  • The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital ( Site 1001)

    Cincinnati, Ohio

  • University of Cincinnati ( Site 1035)

    Cincinnati, Ohio

  • The Cleveland Clinic Foundation Taussig Cancer Center ( Site 1065)

    Cleveland, Ohio

  • Nazih Zuhdi Transplantation Institute ( Site 1084)

    Oklahoma City, Oklahoma

  • Oregon Health & Science University ( Site 1054)

    Portland, Oregon

  • Medical University of South Carolina ( Site 1003)

    Charleston, South Carolina

  • Vanderbilt University Medical Center ( Site 1027)

    Nashville, Tennessee

  • University of Texas Southwestern Medical Center ( Site 1038)

    Dallas, Texas

  • University of Utah ( Site 1049)

    Salt Lake City, Utah

  • Sanatorio Allende ( Site 1908)

    Córdoba, Argentina

  • Hospital Provincial Dr. Jose M. Cullen ( Site 1902)

    Santa Fe, Argentina

  • Cardiologia Palermo ( Site 1911)

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Centro Medico Dra De Salvo ( Site 1904)

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Hospital Universitario Austral ( Site 1901)

    Pilar, Buenos Aires, Argentina

  • Instituto de Investigaciones Clinicas Quilmes ( Site 1903)

    Quilmes, Buenos Aires, Argentina

  • Instituto De Enfermedades Respiratorias E Investigacion Medica ( Site 1910)

    Villa Vatteone, Buenos Aires, Argentina

  • Instituto Médico DAMIC ( Site 1909)

    Córdoba, Córdoba Province, Argentina

  • Instituto Medico Rio Cuarto ( Site 1907)

    Río Cuarto, Córdoba Province, Argentina

  • Hospital Provincial del Centenario ( Site 1912)

    Rosario, Santa Fe Province, Argentina

  • Instituto Cardiovascular de Rosario ( Site 1906)

    Rosario, Santa Fe Province, Argentina

  • Sanatorio Parque ( Site 1905)

    Rosario, Santa Fe Province, Argentina

Showing 40 of 152 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.